Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1985-01-25
1987-09-29
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540492, 540494, 435119, 435913, 435118, A61K 3155, C07D51900, C12P 1718, C12R 166
Patent
active
046969250
ABSTRACT:
Products of Aspergillus alliaceus fermentation having cholecystokinin (CCK) antagonist activity, their preparation and use are disclosed.
REFERENCES:
patent: 4530790 (1985-07-01), Monahan et al.
patent: 4559339 (1985-12-01), Bock et al.
Mutt & Jorpes, Biochem. J. 125 57P (1971).
A. J. Williams, Biomed. Res. 3 (1982).
A. J. Prange et al., Peptides in the Central Nervous System, Ann. Repts. Med Chem. 17 31, 33 (1982).
J. E. Morely, Life Sci. 30 479 (1982).
Goetz Michael A.
Houck David R.
Inamine Edward S.
Abrams Samuel B.
Bond Robert T.
Merck & Co. , Inc.
Pfeiffer Hesna J.
LandOfFree
Cholecystokinin antagonist compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cholecystokinin antagonist compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cholecystokinin antagonist compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1589331